Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation

Ilene C. Weitz, Pedram Razavi, Leanne Rochanda, Jeffrey Zwicker, Bruce Furie, David Manly, Nigel MacKman, Ralph Green, Howard A. Liebman

Research output: Contribution to journalArticle

42 Scopus citations

Fingerprint Dive into the research topics of 'Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation'. Together they form a unique fingerprint.

Medicine & Life Sciences